Published in Neurology on May 02, 2012
Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology (2015) 1.53
Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology (2013) 1.51
Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimers Dement (2014) 0.96
Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease. Nutrients (2014) 0.85
Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation. Oxid Med Cell Longev (2015) 0.85
Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients (2016) 0.82
Nutrition and the risk of Alzheimer's disease. Biomed Res Int (2013) 0.82
ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr (2014) 0.81
Importance and management of micronutrient deficiencies in patients with Alzheimer's disease. Clin Interv Aging (2013) 0.81
Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals. J Nutr Health Aging (2015) 0.80
Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study. BMJ Open (2014) 0.80
Cognition and biomarkers of oxidative stress in obstructive sleep apnea. Clinics (Sao Paulo) (2013) 0.78
Dietary methanol regulates human gene activity. PLoS One (2014) 0.78
Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease. Curr Nutr Rep (2015) 0.76
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid. Mol Neurobiol (2016) 0.76
Exploring Biomarkers for Alzheimer's Disease. J Clin Diagn Res (2016) 0.75
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology (1974) 7.34
Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA (2011) 5.21
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol (2006) 2.98
Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90
Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science (2002) 2.78
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56
Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr (1993) 2.44
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology (2009) 2.39
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci (2005) 2.36
Caloric intake and the risk of Alzheimer disease. Arch Neurol (2002) 2.28
Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol (2003) 2.20
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol (1999) 1.96
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology (2005) 1.62
Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr (1995) 1.57
Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci (2007) 1.47
Diet and Alzheimer's disease. Curr Neurol Neurosci Rep (2007) 1.35
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol Aging (2006) 1.33
Reasonable estimates of serum vitamin E, vitamin C, and beta-cryptoxanthin are obtained with a food frequency questionnaire in older black and white adults. J Nutr (2004) 1.17
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry (2010) 1.13
Plasma ß-amyloid and cognitive decline. Arch Neurol (2010) 1.13
Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis (2007) 1.10
Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A (2003) 1.05
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord (2009) 0.96
Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. Alzheimer Dis Assoc Disord (2011) 0.93
Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia. Am J Epidemiol (2009) 0.92
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol (1992) 2.37
Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry (2009) 1.97
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology (2008) 1.91
Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta (2005) 1.73
Reliability of seizure classification using a semistructured interview. Neurology (1993) 1.71
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology (2006) 1.65
Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients. Neurology (2001) 1.51
Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine. Am J Public Health (1995) 1.46
Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology (2005) 1.45
Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28
Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology (2008) 1.24
Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology (2006) 1.23
Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard (1996) 1.19
Dietary patterns in Alzheimer's disease and cognitive aging. Curr Alzheimer Res (2011) 1.14
Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Transl Psychiatry (2012) 1.07
Prevalence of chronic medical conditions in adults with mental retardation: comparison with the general population. Ment Retard (1998) 1.06
Memory after silent stroke: hippocampus and infarcts both matter. Neurology (2012) 1.05
Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet (2001) 1.05
Body mass index, dementia, and mortality in the elderly. J Nutr Health Aging (2008) 1.04
Dementia of the Alzheimer's type and accelerated aging in Down syndrome. Sci Aging Knowledge Environ (2005) 1.02
Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J Neuroimmunol (1983) 0.99
Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.99
Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry (2008) 0.98
Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment. Neurology (2011) 0.92
Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J Neuroimmunol (1985) 0.92
Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome. Am J Med Genet (1997) 0.88
Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol (1998) 0.86
Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia. Int Psychogeriatr (2013) 0.86
Premature regression of adults with Down syndrome. Am J Ment Defic (1987) 0.85
The epidemiology of Alzheimer disease in intellectual disability: results and recommendations from an international conference. J Intellect Disabil Res (1997) 0.84
IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology (2005) 0.84
Antibody to Thy-1 antigen injected into rat hypothalamus selectively inhibits carbamyl choline induced drinking. Nature (1980) 0.82
Bridging from clinical endpoints to estimates of treatment value for external decision makers. J Nutr Health Aging (2009) 0.81
Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome. Int J Geriatr Psychiatry (2010) 0.81
Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage. Eur Neurol (2008) 0.80
Alzheimer's disease in the parents of women with trisomic spontaneous abortions. Neuroreport (2000) 0.79
Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord (2013) 0.79
Effect of menopause on cognitive performance in women with Down syndrome. Neuroreport (2001) 0.78
Estrogen receptor α variants affect age at onset of Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord (2014) 0.78
Alzheimer neuropathology in mentally retarded adults: statistical independence of regional amyloid plaque and neurofibrillary tangle densities. Acta Neuropathol (1993) 0.77
Complement-dependence of immune complex activity in the rat hypothalamus. Ann N Y Acad Sci (1987) 0.77
Psychopharmacological activity of immune complexes in rat brain is complement dependent. J Neuroimmunol (1987) 0.76
A prospective study of menopause in women with Down's syndrome. J Intellect Disabil Res (2001) 0.76
White Matter Lesions in Femoral Head Osteonecrosis patients: Manifestation of vascular disease or not? Hippokratia (2011) 0.75
Food-motivated behavior in the odd-carbon enriched rat: relationship to maintenance of carbohydrate stores during food deprivation. Physiol Behav (1976) 0.75
Antigen-antibody reactions in rat brain sites induce transient changes in drinking behavior. Science (1977) 0.75
Distribution of apolipoprotein E genotypes in fragile X syndrome and Batten disease. Am J Med Genet (1999) 0.75
Uses of double-pulse stimulation behaviorally to infer refractoriness, summation, convergence, and transmitter characteristics of hypothalamic reward systems. J Comp Physiol Psychol (1976) 0.75
Effect of immune complex-forming reactants on catecholamine-modulated behaviors in the rat hypothalamus. J Neuroimmunol (1985) 0.75
A monoclonal antibody with anti-lipomodulin activity reverses a beta-adrenergic response. Ann N Y Acad Sci (1988) 0.75
The neuropharmacology of immune complex activity in the rat hypothalamus. Ann N Y Acad Sci (1987) 0.75
Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study. Neurology (2007) 0.75